Propiedad y actividad de insiders de Altimmune, Inc. (ALT): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $3.24 |
| Capitalización | $630M |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-08-13 | Durso Jerome Benedict | P-Purchase | 15,000 | $44K |
| 2026-07-31 | WEAVER GREGORY L | A-Award | 1,753 | $4K |
| 2026-07-31 | Roberts M Scot | A-Award | 875 | $2K |
| 2026-05-01 | Lawver Teri L | A-Award | 48,800 | $138K |
| 2026-05-01 | Sohn Catherine A. | A-Award | 48,800 | $138K |
| 2026-05-01 | Jorkasky Diane | A-Award | 48,800 | $138K |
| 2026-05-01 | Schafer Klaus | A-Award | 48,800 | $138K |
| 2026-05-01 | Pisano Wayne | A-Award | 48,800 | $138K |
| 2026-05-01 | Hodges Philip | A-Award | 48,800 | $138K |
| 2026-05-01 | GILL JOHN | A-Award | 48,800 | $138K |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $154.0M | $8.8M | $33.7M | $9.0M | $115.9M | $190.3M | $111.1M | $135.1M | $36.9M | $43.8M |
| Inversiones a Corto | $66.8M | 0 | 0 | $28.3M | $100.0M | 0 | $73.8M | $62.7M | $95.0M | $229.7M |
| Cuentas por Cobrar | $999145 | $10.2M | $4.5M | $1.7M | $12.4M | $5.8M | $2.5M | $4.9M | $3.1M | $1.7M |
| Inventario | 0 | $3.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $222.3M | $23.5M | $39.4M | $39.4M | $230.3M | $204.1M | $192.8M | $209.6M | $137.3M | $278.2M |
| Inmovilizado Material | $120944 | $603146 | $1.3M | $1.8M | $2.0M | $1.4M | $1.1M | $651000 | $413000 | $312000 |
| Fondo de Comercio | $18.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $15.0M | $38.7M | $13.9M | $12.7M | $12.8M | $12.4M | $12.4M | 0 | 0 | 0 |
| Activos Totales | $224.7M | $63.0M | $54.8M | $54.1M | $245.1M | $218.9M | $206.9M | $210.6M | $139.3M | $279.9M |
| Cuentas por Pagar | $2.0M | $129075 | $372860 | $18232 | $612293 | $2.0M | $4.8M | $2.1M | $211000 | $2.7M |
| Deuda a Corto | $458629 | $49702 | $71596 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $204.8M | $3.8M | $4.5M | $3.9M | $12.0M | $18.3M | $17.1M | $12.1M | $10.5M | $15.0M |
| Deuda a Largo | $525950 | $599927 | $501174 | 0 | 0 | 0 | 0 | 0 | 0 | $34.3M |
| Pasivos Totales | $205.3M | $14.4M | $6.4M | $8.5M | $19.2M | $19.7M | $21.6M | $16.5M | $15.8M | $55.0M |
| Reservas | -$29.9M | -$77.7M | -$116.9M | -$137.4M | -$186.4M | -$293.2M | -$377.9M | -$466.3M | -$561.4M | -$649.5M |
| Patrimonio Neto | $19.5M | $48.7M | $48.3M | $45.5M | $225.9M | $199.1M | $185.3M | $194.1M | $123.5M | $224.9M |
| Deuda Total | $984580 | $49702 | $572770 | $1.7M | $1.8M | $1.5M | $1.1M | $671000 | $1.7M | $35.7M |
| Deuda Neta | -$219.8M | -$8.7M | -$33.1M | -$35.5M | -$214.1M | -$188.8M | -$183.8M | -$197.1M | -$130.2M | -$237.8M |
| Capital Circulante | $17.4M | $19.6M | $34.8M | $35.5M | $218.2M | $185.8M | $175.8M | $197.5M | $126.8M | $263.2M |
Salud financiera
| Deuda / Patrimonio | 0.08 |
| Ratio corriente | 26.78 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 0.23 |
Rentabilidad
| Rentabilidad sobre capital | -31.41% |
| Rentabilidad sobre capital invertido | -19.47% |
| Rentabilidad sobre activos | -17.40% |
| Margen bruto | -48306.45% |
| Margen operativo | -323306.45% |
| Margen neto | -296000.00% |
Empresas relacionadas: ACIU · AMRN · ANNX · ANRO · AURA · DBVT · ENGN
Explorar sector: Healthcare · Biotechnology
Más secciones de ALT: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones